On European Prostate Cancer Awareness Day, experts, policy makers, and patient representatives will gather to explore how public policies can dramatically improve screening and early detection.
The event takes place in the European Parliament on Wednesday 3 September, 14:30-16:00 CEST. Register here.
There is good evidence that PSA tests and MRI (Magnetic Resonance Imaging) can save lives. But how do we create policies and programmes that make these tests readily available?
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959